Josh Thomas Georgy
Overview
Explore the profile of Josh Thomas Georgy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thomas Z, Georgy J, Ponmar M, Thumaty D, Prabhu A, Singh A
Int J Surg Pathol
. 2024 Oct;
:10668969241286068.
PMID: 39350761
Pseudomyogenic hemangioendothelioma (PMHE), a rare soft tissue tumor predominantly affecting young adults, often presents as multiple nodules in various tissue planes of a limb. Malignant transformation and metastatic disease are...
2.
Bright H, Singh A, Joel A, Georgy J, John A, Rajkumar P, et al.
JCO Glob Oncol
. 2024 Jun;
10:e2400130.
PMID: 38905580
Purpose: We examined the efficacy of topical capsaicin in reducing delayed chemotherapy-induced nausea and vomiting (CINV). Methods: Adults on highly emetogenic chemotherapy regimens applied 2 g of capsaicin ointment (0.075%)...
3.
John A, Singh A, Yadav P, Joel A, Thumaty D, Fibi Ninan K, et al.
Eur J Hum Genet
. 2024 Mar;
32(10):1319-1326.
PMID: 38538877
Mutations in BRCA1 and BRCA2 significantly elevate the risk of developing breast and ovarian cancer. Limited data exists regarding the prevalence of BRCA mutations, and optimal, cost-effective testing strategies in...
4.
S B M, Chacko B, Selvarajan S, Peter J, Geevar T, Dave R, et al.
Sci Rep
. 2024 Jan;
14(1):2011.
PMID: 38263377
Prospective and sequential evaluation of homeostatic changes leading to thrombosis across COVID 19 disease severity spectrum are limited. In this prospective observational study, haemostasis was evaluated in patients with mild,...
5.
Singh A, Georgy J, Dhananjayan S, Sigamani E, John A, Joel A, et al.
Gene
. 2023 Nov;
895:147980.
PMID: 37951371
Triple-negative breast cancer (TNBC) is a heterogeneous disease with poor survival compared to other subtypes. Patients with residual disease after neoadjuvant chemotherapy (NAC) face an increased risk of relapse and...
6.
Singh A, Georgy J, Joel A, Thumaty D, John A, Ramnath N, et al.
Cancer Invest
. 2023 Nov;
41(9):789-802.
PMID: 37909664
We assessed the efficacy, tolerability, and cost-effectiveness of a novel neoadjuvant regimen comprising docetaxel-cyclophosphamide alternating with epirubicin-cisplatin (ddDCEP) administered biweekly for 16 weeks in 116 patients with early triple-negative breast...
7.
John A, Singh A, Bala D, Joel A, Georgy J, Jesudasan M, et al.
J Gastrointest Cancer
. 2023 Jul;
55(1):307-317.
PMID: 37479897
Purpose: Total neoadjuvant therapy (TNT) with pre-operative chemotherapy and chemoradiotherapy results in improved survival and is becoming the new standard of care in locally advanced rectal cancer (LARC). We describe...
8.
Joel A, Singh A, Hepzibah J, Devasia A, Kumar S, Gnanamuthu B, et al.
South Asian J Cancer
. 2023 Feb;
11(4):315-321.
PMID: 36756102
Anjana Joel Patients with seminoma present with advanced disease. End-of-treatment (EOT) positron emission tomography-computed tomography (PET-CT) is done to assess response and direct management of post-chemotherapy residual masses. This article...
9.
Jose N, Joel A, Selvakumar R, Ramireddy J, John A, Georgy J, et al.
J Egypt Natl Canc Inst
. 2022 May;
34(1):22.
PMID: 35599280
Background: The administration of 5-fluorouracil (5FU) in the treatment of gastrointestinal (GI) malignancies is associated with common side effects such as mucositis, diarrhoea, and myelosuppression, which are easily managed with...
10.
Sharma P, Georgy J, Andrews A, John A, Joel A, Chacko R, et al.
Support Care Cancer
. 2022 Mar;
30(6):5519-5526.
PMID: 35314996
Purpose: Dose-dense chemotherapy improves survival but with increased toxicity and treatment-related cost. We report the prevalence of anemia and the possible risk factors associated with chemotherapy-related anemia and determine the...